Clinical neurorestorative progress in amyotrophic lateral sclerosis

被引：4

作者：

Chen, Lin ^{[1
,2
]}

Huang, Hongyun ^{[3
]}

Xi, Haitao ^{[4
,5
]}

Mao, Gengsheng ^{[3
]}

机构：

[1] Tsinghua Univ, Med Ctr, Beijing, Peoples R China

[2] Tsinghua Univ, Yuquan Hosp, 5 Shijingshan Rd, Beijing, Peoples R China

[3] Gen Hosp Chinese Peoples Armed Police Forces, Beijing, Peoples R China

[4] Capital Med Univ, Beijing Rehabil Hosp, Beijing, Peoples R China

[5] Beijing Hongtianji Neurosci Acad, Beijing, Peoples R China

来源：

JOURNAL OF NEURORESTORATOLOGY | 2015年 / 3卷

关键词：

amyotrophic lateral sclerosis; neurorestorative treatment; cell transplantation; clinical trial;

D O I：

10.2147/JN.S74145

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease characterized by progressive paralysis and motor neuron death. In addition to symptomatic managements such as ventilation and nutritional support, neurorestorative therapies have demonstrated anti-neurodegenerative potential and may improve quality of life for patients. Currently, clinical neurorestorative strategies include pharmacological management (granulocyte colony stimulating factor), neuromodulatory intervention (repetitive transcranial magnetic and cortical stimulation), cell transplantation (bone marrow stromal cells, olfactory ensheathing cells, granulocyte colony stimulating factor-mobilized peripheral blood stromal cells, hematopoietic stem and progenitor cells, neural stem/progenitor cells, CD133(+) cells and CD34(+) cells), bioengineering and tissue engineering therapy, and combined neurorehabilitative treatment. In this review, we describe the latest progress in clinical neurorestorative management of amyotrophic lateral sclerosis and discuss the underlying evidence base.

引用

页码：109 / 114

页数：6

共 63 条

[1] Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients [J].

Aebischer, P ;

Schluep, M ;

Deglon, N ;

Joseph, JM ;

Hirt, L ;

Heyd, B ;

Goddard, M ;

Hammang, JP ;

Zurn, AD ;

Kato, AC ;

Regli, F ;

Baetge, EE .

NATURE MEDICINE, 1996, 2 (06) :696-699

[2] Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF [J].

Aebischer, P ;

Pochon, NAM ;

Heyd, B ;

Deglon, N ;

Joseph, JM ;

Zurn, AD ;

Baetge, EE ;

Hammang, JP ;

Goddard, M ;

Lysaght, M ;

Kaplan, F ;

Kato, AC ;

Schluep, M ;

Hirt, L ;

Regli, F ;

Porchet, F ;

DeTribolet, N .

HUMAN GENE THERAPY, 1996, 7 (07) :851-860

[3] Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis [J].

Appel, S. H. ;

Engelhardt, J. I. ;

Henkel, J. S. ;

Siklos, L. ;

Beers, D. R. ;

Yen, A. A. ;

Simpson, E. P. ;

Luo, Y. ;

Carrum, G. ;

Heslop, H. E. ;

Brenner, M. K. ;

Popat, U. .

NEUROLOGY, 2008, 71 (17) :1326-1334

[4] Systematic Review of the Effectiveness of Occupational Therapy-Related Interventions for People With Amyotrophic Lateral Sclerosis [J].

Arbesman, Marian ;

Sheard, Kendra .

AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 2014, 68 (01) :20-26

[5] Clinical and biological changes under treatment with lithium carbonate and valproic acid in sporadic amyotrophic lateral sclerosis [J].

Boll, Marie-Catherine ;

Bayliss, Leo ;

Vargas-Canas, Steven ;

Burgos, Jorge ;

Montes, Sergio ;

Penaloza-Solano, Guillermo ;

Rios, Camilo ;

Alcaraz-Zubeldia, Mireya .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) :103-108

[6] Metalloproteinase alterations in the bone marrow of ALS patients [J].

Bossolasco, Patrizia ;

Cova, Lidia ;

Calzarossa, Cinzia ;

Servida, Federica ;

Mencacci, Niccolo Emanuele ;

Onida, Francesco ;

Polli, Elio ;

Deliliers, Giorgio Lambertenghi ;

Silani, Vincenzo .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (06) :553-564

[7] PROXIMAL AXONAL ENLARGEMENT IN MOTOR NEURON DISEASE [J].

CARPENTER, S .

NEUROLOGY, 1968, 18 (09) :841-+

[8] Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS) [J].

Cashman, Neil ;

Tan, Lih-Yeen ;

Krieger, Charles ;

Madler, Burkhard ;

Mackay, Alex ;

Mackenzie, Ian ;

Benny, Barrett ;

Nantel, Stephen ;

Fabros, Marife ;

Shinobu, Leslie ;

Yousefi, Masoud ;

Eisen, Andrew .

MUSCLE & NERVE, 2008, 37 (05) :620-625

[9] Olfactory Ensheathing Cell Neurorestorotherapy for Amyotrophic Lateral Sclerosis Patients: Benefits From Multiple Transplantations [J].

Chen, Lin ;

Chen, Di ;

Xi, Haitao ;

Wang, Qingmiao ;

Liu, Yancheng ;

Zhang, Feng ;

Wang, Hongmei ;

Ren, Yushui ;

Xiao, Juan ;

Wang, Yuanchao ;

Huang, Hongyun .

CELL TRANSPLANTATION, 2012, 21 :S65-S77

[10] Intracranial Transplant of Olfactory Ensheathing Cells in Children and Adolescents With Cerebral Palsy: A Randomized Controlled Clinical Trial [J].

Chen, Lin ;

Huang, Hongyun ;

Xi, Haitao ;

Xie, Zihang ;

Liu, Ruiwen ;

Jiang, Zhao ;

Zhang, Feng ;

Liu, Yancheng ;

Chen, Di ;

Wang, Qingmiao ;

Wang, Hongmei ;

Ren, Yushui ;

Zhou, Changman .

CELL TRANSPLANTATION, 2010, 19 (02) :185-191

← 1 2 3 4 5 6 7 →